Early research (Phase 1)Study completedNCT03926819
What this trial is testing
Assess the Safety and Pharmacokinetics of HBI-002, an Oral Carbon Monoxide Therapeutic, in Healthy Volunteers
Who this might be right for
Anemia, Sickle Cell
Hillhurst Biopharmaceuticals, Inc. 20